Innovative Health Care, 20

Trust Performance (as of 11/22/2024)

*Inception Date is 3/18/2024

Cumulative Total Return

Average Annual Total Return

YTD

Since
Inception^*

3 mo

6 mo

1 yr

3 yr

5 yr

10 yr

Since
Inception^*

Distributions Reinvested

With Transactional Sales Charge	N/A	-3.25%	-8.49%	-4.96%	N/A	N/A	N/A	N/A	N/A
Without Transactional Sales Charge	N/A	-1.93%	-7.24%	-3.65%	N/A	N/A	N/A	N/A	N/A

Distributions Received in Cash

With Transactional Sales Charge	N/A	-3.25%	-8.49%	-4.96%	N/A	N/A	N/A	N/A	N/A
Without Transactional Sales Charge	N/A	-1.93%	-7.24%	-3.65%	N/A	N/A	N/A	N/A	N/A

HEALTH CARE SEL SECTOR IDX (IXV)	N/A	0.38%	-6.44%	-0.77%	N/A	N/A	N/A	N/A	N/A
S&P 500 (SPX)	N/A	16.97%	7.51%	13.23%	N/A	N/A	N/A	N/A	N/A

Performance Calculator

From Date:

To Date:

Cumulative
Total Return

Average Annual
Total Return

With Transactional Sales Charge (Distributions Reinvested)	-3.25%	N/A
Without Transactional Sales Charge (Distributions Reinvested)	-1.93%	N/A
With Transactional Sales Charge (Distributions Received in Cash)	-3.25%	N/A
Without Transactional Sales Charge (Distributions Received in Cash)	-1.93%	N/A
S&P 500 (SPX)	16.97%	N/A
HEALTH CARE SEL SECTOR IDX (IXV)	0.38%	N/A

Sales Charges (based on a $10 public offering price)

Standard Accounts
Transactional Sales Charges:	Initial:	0.00%
	Deferred:	1.35%
Creation & Development Fee:		0.50%
Maximum Sales Charge:		1.85%

Fee/Wrap Accounts
Creation & Development Fee:	0.50%
Maximum Sales Charge:	0.50%

The table above shows the initial offering period sales charge. Certain performance periods shown on this page may begin after the end of the initial offering period and reflect a secondary market sales charge. Please see the prospectus for sales charge details, including the secondary market sales charge amount applicable to a period.

Past Performance is no indication of future results. Investment returns and principal value will fluctuate and units when sold or redeemed, may be worth more or less than their original cost. All returns are historical and do not represent potential future performance. This report is not and should not be construed as an offer to buy or sell securities.

Unless an index is indicated to be a price only index, all index returns assume that dividends are reinvested when they are received.

Returns With Transactional Sales Charge reflect the maximum transactional sales charge that would be payable by an investor upon sale or redemption of units at the end of the applicable period(s). The transactional sales charge includes any initial or deferred sales charges other than the creation and development fee. These returns do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.

Returns Without Transactional Sales Charge do not reflect any transactional sales charge and do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.

If applicable, returns shown with distributions reinvested assume distributions are reinvested on the reinvestment date.

Risk Considerations

Buy & Hold Risk – Taxable Trusts. This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

Closed-End Fund and ETF Risk. Closed-end funds and ETFs are subject to various risks, including management's ability to meet the fund's investment objective, and to manage the fund's portfolio when the underlying securities are redeemed or sold, during periods of market turmoil and as investors' perceptions regarding ETFs, closed-end funds or their underlying investments change. Unlike open-end funds, which trade at prices based on a current determination of the fund's net asset value, ETFs and closed-end funds frequently trade at a discount from their net asset value in the secondary market. The funds may employ the use of leverage which increases the volatility of such funds.

Closed-End Fund Risk. Closed-end funds are subject to various risks, including management's ability to meet the fund's investment objective, and to manage the fund's portfolio when the underlying securities are redeemed or sold, during periods of market turmoil and as investors' perceptions regarding the funds or their underlying investments change. Unlike open-end funds, which trade at prices based on a current determination of the fund's net asset value, closed-end funds frequently trade at a discount to their net asset value in the secondary market. Certain closed-end funds employ the use of leverage, which increases the volatility of such funds.

COVID-19 Economic Impact Risk. The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.

Health Care Risk. The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, health crises, such as a pandemic outbreak, can severely impact the health care industry in particular.

Large-Cap Risk. Large capitalization companies may grow at a slower rate than the overall market.

Market Disruption Risk. Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.

Additional Risk. For a discussion of additional risks of investing in the trust see the "Risk Factors" section of the prospectus.

Important Note. It is important to note that an investment can be made in the underlying funds directly rather than through the trust. These direct investments can be made without paying the trust's sales charge, operating expenses and organizational costs.

Operational Risk. As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

You should carefully consider the trust's investment objectives, risks, and charges and expenses before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the trust. Read it carefully before you invest.

This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.

Not FDIC Insured, Not Bank Guaranteed and May Lose Value.

CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.

Fund Cusip Information

30335B181	(Cash)
30335B199	(Reinvest)
30335B207	(Cash-Fee)
30335B215	(Reinvest-Fee)

Printer Friendly Page